Key genes for Spanish flu pandemic exist in nature

Key genes for Spanish flu pandemic exist in nature

Thursday, Jun 12, 2014
AFP

WASHINGTON – Bird flu viruses circulating in nature contain eight genes key to potentially recreate a pathogen similar to that which caused the 1918 deadly Spanish flu pandemic, a study published on Wednesday said.

An international team of virologists identified the key genetic components – similar to those in the virus behind the 1918 pandemic – in influenza viruses in wild ducks.

“There are gene pools in nature that have the potential to cause a severe pandemic in the future,” said the report’s senior author and lead researcher Yoshihiro Kawaoka of the University of Wisconsin-Madison, whose work was published in the journal Cell Host and Microbe.

The Spanish flu was responsible for 40 million deaths worldwide.

The scientists used reverse genetic methods to recreate a virus that differed from that of the Spanish flu by only three per cent of the amino acids that make the virus proteins.

In the animals it was tested on, the new virus was less pathogenic than the Spanish flu – but more so than avian flu – and, at least in ferrets, didn’t transfer via respiratory droplets, the main way the flu virus spreads.

However, the scientists then discovered seven mutations in three virus genes that allowed it to spread as easily as the Spanish flu in ferrets, an animal commonly used in influenza transmission studies.

Consisting of genetic factors already present in wild bird populations, the virus showed that genetic ingredients capable of combining to create a dangerous pathogen that could produce a human pandemic exist in nature.

According to Kawaoka, the discovery could help scientists develop more effective strategies to combat the emergence of such a disease.

The research also shines light on the bird flu virus’s adaptive mechanisms for spreading to mammals.

A mutation of a protein on the surface of the virus, for example, allows it to cling to an organism’s cells and could increase the virus’s ability to infect human respiratory tracts.

The researchers also discovered that the virus they created reacted to the current vaccine against seasonal flu – which is effective against H1N1 flu responsible for a 2009 pandemic – indicating that the current vaccine could offer protection against a pandemic.

The scientists also noted that the virus was sensitive to oseltamivir, an antiviral medication to prevent and slow the flu.

 

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment